A GLP-1 receptor agonist is a medicine that mimics glucagon-like peptide-1 (GLP-1), a hormone your body naturally releases after eating. These medicines can boost insulin release when blood sugar is high, reduce another hormone called glucagon, slow down stomach emptying, and change how full you feel.
Semaglutide and liraglutide are two examples. In Australia, different brands are approved for different purposes — some for type 2 diabetes, others for long-term weight management — and a brand approved for one use isn't automatically approved for the other, even if the active ingredient is similar.
These are prescription-only medicines and are not a form of insulin. Side effects most often affect the digestive system, though serious side effects are possible. A doctor decides whether one of these medicines is suitable and monitors how a patient responds to it.
Book a telehealth consultation with an AHPRA-registered GP for assessment, prescriptions, referrals or advice.
Book ConsultationA GLP-1 receptor agonist is a prescription medicine that copies a natural gut hormone to help control blood sugar, appetite and digestion.
No. This glossary explains general health terminology, not your individual symptoms or test results. Speak with a qualified health professional for advice about your circumstances. For a medical emergency, call 000.
Proudly Australian-owned and operated